Loading clinical trials...
Loading clinical trials...
Open, Single-Arm Phase II Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer Expressing the Estrogen and/or Progesterone Receptor
Conditions
Interventions
Tamoxifen
Zarnestra
Locations
3
France
Institut Bergonie
Bordeaux, France
Institut Val d'Aurelle_ Paul Lamarque
Montpellier, France
Institut Claudius Regaud
Toulouse, France
Start Date
August 1, 2003
Completion Date
August 1, 2008
Last Updated
November 14, 2006
NCT07191730
NCT06797635
NCT06312176
NCT07003841
NCT07396766
NCT06443645
Lead Sponsor
Institut Claudius Regaud
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions